Cardiac Prosthetic Devices Market to record USD 5.87 Bn growth — Driven by rising prevalence of cardiac disorders

NEW YORK, Aug. 26, 2022 /PRNewswire/ — The “Cardiac Prosthetic Devices Market by Product and Geography – Forecast and Analysis 2022-2026” report has been added to Technavio’s offering. According to the report, the market will observe an incremental growth of USD 5.87 billion between 2021 and 2026, expanding at a CAGR of 8.02% during the forecast period. The analysts at Technavio have considered various aspects such as the consumer base, adoption rate, average selling price, revenue generated by vendors, and the food preferences across regions to estimate the market size. Download Sample PDF Report

The global cardiac prosthetic devices market is fragmented and is characterized by the presence of many vendors. Vendors are increasing their R&D investment to develop technologically advanced cardiac prosthetic devices. They compete in the development of technologically advanced cardiac prosthetic devices, price reductions, and expanding their presence in untapped markets. Vendors are implementing innovative strategies to remain competitive in the market. Vendors are also focusing on their product pipelines and undergoing strategic alliances with other companies to expand their presence and improve their technologies.

The key vendors in the market include Abbott Laboratories, Anteris Technologies Ltd., BIOTRONIK SE and Co KG, Boston Scientific Corp., Braile Biomedica, Colibri Heart Valve LLC, Cryolife Inc., Edwards Lifesciences Corp., Jc Medical Inc., JenaValve Technology Inc., Lepu Medical Technology Beijing Co. Ltd., LivaNova Plc, Medtronic Plc, Meril Life Sciences Pvt. Ltd., Merit Medical Systems Inc., MicroPort Scientific Corp., OrbusNeich Medical Co. Ltd., Shree Pacetronix Ltd., TTK Healthcare Ltd., and Venus Medtech Hangzhou Inc.

Although the rising prevalence of cardiac disorders will offer immense growth opportunities, complications associated with the implantation of cardiac prosthetic devices will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. View Sample Report Here

The cardiac prosthetic devices market is segmented as below:

  • Product
    • Prosthetic Heart Valves
    • Implantable Pacemakers

The prosthetic heart valves segment will record the maximum growth in the market during the forecast period. Factors such as the rise in the procedural volume, growing prevalence of valvular heart disease, and growing older adult population across various regions such as Europe are driving the growth of the segment.

  • Geography
    • North America
    • Europe
    • Asia
    • Rest Of World (ROW)

The cardiac prosthetic devices market in North America is growing significantly. The region will account for 42% of the market growth over the forecast period. The rise in the adoption of tissue valves, the increase in the adoption of MI procedures, and the growing geriatric population are driving the growth of the regional market. Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our cardiac prosthetic devices market report covers the following areas:

Cardiac Prosthetic Devices Market 2022-2026: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the cardiac prosthetic devices market. Backed with competitive intelligence and benchmarking, our research reports on the cardiac prosthetic devices market are designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

Cardiac Prosthetic Devices Market 2022-2026: Key Highlights

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will assist cardiac prosthetic devices market growth during the next five years
  • Estimation of the cardiac prosthetic devices market size and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • The growth of the cardiac prosthetic devices market
  • Analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of cardiac prosthetic devices market vendors

Related Reports:

Cardiac Prosthetic Devices Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 8.02%

Market growth 2022-2026

USD 5.87 billion

Market structure

Fragmented

YoY growth (%)

7.42

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Anteris Technologies Ltd., BIOTRONIK SE and Co KG, Boston Scientific Corp., Braile Biomedica, Colibri Heart Valve LLC, Cryolife Inc., Edwards Lifesciences Corp., Jc Medical Inc., JenaValve Technology Inc., Lepu Medical Technology Beijing Co. Ltd., LivaNova Plc, Medtronic Plc, Meril Life Sciences Pvt. Ltd., Merit Medical Systems Inc., MicroPort Scientific Corp., OrbusNeich Medical Co. Ltd., Shree Pacetronix Ltd., TTK Healthcare Ltd., and Venus Medtech Hangzhou Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table Of Contents:

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
    • Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
    • Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
    • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
    • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
    • Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
    • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
    • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
    • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
    • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
    • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
  • 4.7 Market condition
    • Exhibit 23: Chart on Market condition – Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
    • Exhibit 24: Chart on Product – Market share 2021-2026 (%)
    • Exhibit 25: Data Table on Product – Market share 2021-2026 (%)
  • 5.2 Comparison by Product
    • Exhibit 26: Chart on Comparison by Product
    • Exhibit 27: Data Table on Comparison by Product
  • 5.3 Prosthetic heart valves – Market size and forecast 2021-2026
    • Exhibit 28: Chart on Prosthetic heart valves – Market size and forecast 2021-2026 ($ million)
    • Exhibit 29: Data Table on Prosthetic heart valves – Market size and forecast 2021-2026 ($ million)
    • Exhibit 30: Chart on Prosthetic heart valves – Year-over-year growth 2021-2026 (%)
    • Exhibit 31: Data Table on Prosthetic heart valves – Year-over-year growth 2021-2026 (%)
  • 5.4 Implantable pacemakers – Market size and forecast 2021-2026
    • Exhibit 32: Chart on Implantable pacemakers – Market size and forecast 2021-2026 ($ million)
    • Exhibit 33: Data Table on Implantable pacemakers – Market size and forecast 2021-2026 ($ million)
    • Exhibit 34: Chart on Implantable pacemakers – Year-over-year growth 2021-2026 (%)
    • Exhibit 35: Data Table on Implantable pacemakers – Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Product
    • Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
    • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
    • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
    • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
  • 7.2 Geographic comparison
    • Exhibit 40: Chart on Geographic comparison
    • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America – Market size and forecast 2021-2026
    • Exhibit 42: Chart on North America – Market size and forecast 2021-2026 ($ million)
    • Exhibit 43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
    • Exhibit 44: Chart on North America – Year-over-year growth 2021-2026 (%)
    • Exhibit 45: Data Table on North America – Year-over-year growth 2021-2026 (%)
  • 7.4 Europe – Market size and forecast 2021-2026
    • Exhibit 46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
    • Exhibit 47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
    • Exhibit 48: Chart on Europe – Year-over-year growth 2021-2026 (%)
    • Exhibit 49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
  • 7.5 Asia – Market size and forecast 2021-2026
    • Exhibit 50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
    • Exhibit 51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
    • Exhibit 52: Chart on Asia – Year-over-year growth 2021-2026 (%)
    • Exhibit 53: Data Table on Asia – Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
    • Exhibit 54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
    • Exhibit 55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
    • Exhibit 56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
    • Exhibit 57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
  • 7.7 US – Market size and forecast 2021-2026
    • Exhibit 58: Chart on US – Market size and forecast 2021-2026 ($ million)
    • Exhibit 59: Data Table on US – Market size and forecast 2021-2026 ($ million)
    • Exhibit 60: Chart on US – Year-over-year growth 2021-2026 (%)
    • Exhibit 61: Data Table on US – Year-over-year growth 2021-2026 (%)
  • 7.8 Germany – Market size and forecast 2021-2026
    • Exhibit 62: Chart on Germany – Market size and forecast 2021-2026 ($ million)
    • Exhibit 63: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
    • Exhibit 64: Chart on Germany – Year-over-year growth 2021-2026 (%)
    • Exhibit 65: Data Table on Germany – Year-over-year growth 2021-2026 (%)
  • 7.9 UK – Market size and forecast 2021-2026
    • Exhibit 66: Chart on UK – Market size and forecast 2021-2026 ($ million)
    • Exhibit 67: Data Table on UK – Market size and forecast 2021-2026 ($ million)
    • Exhibit 68: Chart on UK – Year-over-year growth 2021-2026 (%)
    • Exhibit 69: Data Table on UK – Year-over-year growth 2021-2026 (%)
  • 7.10 China – Market size and forecast 2021-2026
    • Exhibit 70: Chart on China – Market size and forecast 2021-2026 ($ million)
    • Exhibit 71: Data Table on China – Market size and forecast 2021-2026 ($ million)
    • Exhibit 72: Chart on China – Year-over-year growth 2021-2026 (%)
    • Exhibit 73: Data Table on China – Year-over-year growth 2021-2026 (%)
  • 7.11 Canada – Market size and forecast 2021-2026
    • Exhibit 74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
    • Exhibit 75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
    • Exhibit 76: Chart on Canada – Year-over-year growth 2021-2026 (%)
    • Exhibit 77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity by geography
    • Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
    • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
    • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
    • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
    • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
    • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
    • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Abbott Laboratories
    • Exhibit 85: Abbott Laboratories – Overview
    • Exhibit 86: Abbott Laboratories – Business segments
    • Exhibit 87: Abbott Laboratories – Key news
    • Exhibit 88: Abbott Laboratories – Key offerings
    • Exhibit 89: Abbott Laboratories – Segment focus
  • 10.4 BIOTRONIK SE and Co KG
    • Exhibit 90: BIOTRONIK SE and Co KG – Overview
    • Exhibit 91: BIOTRONIK SE and Co KG – Product / Service
    • Exhibit 92: BIOTRONIK SE and Co KG – Key offerings
  • 10.5 Boston Scientific Corp.
    • Exhibit 93: Boston Scientific Corp. – Overview
    • Exhibit 94: Boston Scientific Corp. – Business segments
    • Exhibit 95: Boston Scientific Corp. – Key news
    • Exhibit 96: Boston Scientific Corp. – Key offerings
    • Exhibit 97: Boston Scientific Corp. – Segment focus
  • 10.6 Colibri Heart Valve LLC
    • Exhibit 98: Colibri Heart Valve LLC – Overview
    • Exhibit 99: Colibri Heart Valve LLC – Product / Service
    • Exhibit 100: Colibri Heart Valve LLC – Key offerings
  • 10.7 Cryolife Inc.
    • Exhibit 101: Cryolife Inc. – Overview
    • Exhibit 102: Cryolife Inc. – Business segments
    • Exhibit 103: Cryolife Inc. – Key offerings
    • Exhibit 104: Cryolife Inc. – Segment focus
  • 10.8 Edwards Lifesciences Corp.
    • Exhibit 105: Edwards Lifesciences Corp. – Overview
    • Exhibit 106: Edwards Lifesciences Corp. – Business segments
    • Exhibit 107: Edwards Lifesciences Corp. – Key offerings
    • Exhibit 108: Edwards Lifesciences Corp. – Segment focus
  • 10.9 Lepu Medical Technology Beijing Co. Ltd.
    • Exhibit 109: Lepu Medical Technology Beijing Co. Ltd. – Overview
    • Exhibit 110: Lepu Medical Technology Beijing Co. Ltd. – Product / Service
    • Exhibit 111: Lepu Medical Technology Beijing Co. Ltd. – Key offerings
  • 10.10 LivaNova Plc
    • Exhibit 112: LivaNova Plc – Overview
    • Exhibit 113: LivaNova Plc – Business segments
    • Exhibit 114: LivaNova Plc – Key offerings
    • Exhibit 115: LivaNova Plc – Segment focus
  • 10.11 Medtronic Plc
    • Exhibit 116: Medtronic Plc – Overview
    • Exhibit 117: Medtronic Plc – Business segments
    • Exhibit 118: Medtronic Plc – Key news
    • Exhibit 119: Medtronic Plc – Key offerings
    • Exhibit 120: Medtronic Plc – Segment focus
  • 10.12 Meril Life Sciences Pvt. Ltd.
    • Exhibit 121: Meril Life Sciences Pvt. Ltd. – Overview
    • Exhibit 122: Meril Life Sciences Pvt. Ltd. – Product / Service
    • Exhibit 123: Meril Life Sciences Pvt. Ltd. – Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
    • Exhibit 124: Inclusions checklist
    • Exhibit 125: Exclusions checklist
  • 11.3 Currency conversion rates for US$
    • Exhibit 126: Currency conversion rates for US$
  • 11.4 Research methodology
    • Exhibit 127: Research methodology
    • Exhibit 128: Validation techniques employed for market sizing
    • Exhibit 129: Information sources
  • 11.5 List of abbreviations
    • Exhibit 130: List of abbreviations
About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cardiac-prosthetic-devices-market-to-record-usd-5-87-bn-growth–driven-by-rising-prevalence-of-cardiac-disorders-301612273.html

SOURCE Technavio

Cardiac Prosthetic Devices Market to record USD 5.87 Bn growth -- Driven by rising prevalence of cardiac disorders WeeklyReviewer

PR Newswire Science News

Earnings Disclosure

WeeklyReviewer earns primarily through affiliates and ads. We don’t encourage anyone to click on ads for any other purpose but your own. We recommend products and services often for our readers, and through many we will earn commissions through affiliate programs.

WeeklyReviewer earns commissions through affiliates of qualifying products through Amazon Associates, Fiverr Affiliates, Hostgator Affiliates, Namecheap Affiliates, NordVPN Affiliates, Semrush Affiliates, Alibaba Affiliates, Clickfunnels Affiliate, Leadpages Affiliates, Cryptohopper Affiliates, Binance Affiliates and more.

Clicking on links in WeeklyReviewer may or may not provide us commission through any qualifying purchases.

World Reviewer Staff
World Reviewer Staffhttps://weeklyreviewer.com/
The first logical thought has to be "no way". I'm the World Observer! Ill find and share important news all day.

Latest articles

Related articles

WeeklyReviewer